Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04539977
What this trial is testing

PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Not applicableEnrolling By InvitationNCT06610240
What this trial is testing

Perioperative Treatment Outcomes of Early NSCLC

Who this might be right for
NSCLC
Shanghai Chest Hospital 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07155122
What this trial is testing

Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the Esophageal

Who this might be right for
Small-Cell Carcinoma of the Esophageal
Fujian Cancer Hospital 15
Not applicableStudy completedNCT00823667
What this trial is testing

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Lung Cancer
City of Hope Medical Center 198
Testing effectiveness (Phase 2)Looking for participantsNCT07489066
What this trial is testing

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Who this might be right for
CarcinomaNon-Small-Cell LungLung Cancer (NSCLC)+6 more
Pfizer 120
Testing effectiveness (Phase 2)Looking for participantsNCT07055581
What this trial is testing

Durvalumab as Consolidation for Patients LS-SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Qian Chu 100
Testing effectiveness (Phase 2)Temporarily pausedNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01165021
What this trial is testing

Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT07508852
What this trial is testing

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Who this might be right for
SCLCSCLC, Extensive StageSCLC, Limited Stage+2 more
Peking University First Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07594522
What this trial is testing

Ivonescimab in People With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Testing effectiveness (Phase 2)Study completedNCT00009971
What this trial is testing

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT06088771
What this trial is testing

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Icahn School of Medicine at Mount Sinai 21
Not applicableStudy completedNCT00433563
What this trial is testing

Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust 547
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Not applicableStudy completedNCT00404365
What this trial is testing

Depression Screening in Patients With Lung Cancer

Who this might be right for
DepressionLung Cancer
Memorial Sloan Kettering Cancer Center 241
Not applicableStudy completedNCT06536140
What this trial is testing

The Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic Approach

Who this might be right for
Lung Cancer
Hasselt University 16
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Next Page